ANI Pharmaceuticals (ANIP) EPS (2010 - 2026)
ANI Pharmaceuticals (ANIP) EPS from Jun 30, 2010 to Mar 31, 2026. The TTM ANI Pharmaceuticals (ANIP) EPS is $3.97. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
ANI Pharmaceuticals (ANIP) EPS CAGR table
| Period | CAGR |
|---|---|
| 10 Years TTM | +14.28% |
Annual EPS change of ANI Pharmaceuticals (ANIP)
| Year | EPS | Change |
|---|---|---|
| 2026 | $1.41 | -59.52% |
| 2025 | $3.48 | -496.99% |
| 2024 | -$0.88 | -184.10% |
| 2023 | $1.04 | -135.41% |
| 2022 | -$2.95 | -12.90% |
| 2021 | -$3.38 | +79.43% |
| 2020 | -$1.88 | -466.47% |
| 2019 | $0.51 | -61.23% |
| 2018 | $1.33 | -1518.29% |
| 2017 | -$0.09 | -127.24% |
| 2016 | $0.34 | -74.61% |
| 2015 | $1.35 | -48.52% |
| 2014 | $2.63 | +1993.35% |
| 2013 | $0.13 | -130.15% |
| 2012 | -$0.42 | -97.80% |
| 2011 | -$18.88 | -25.16% |
| 2010 | -$25.23 | +200.42% |
| 2009 | -$8.40 | N/A |
Comparison ANI Pharmaceuticals (ANIP) five years EPS CAGR with competitors
ANI Pharmaceuticals (ANIP) five years EPS CAGR is 25.74%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 101.37% | +293.79% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.58% | +11.03% |
| RGC | Regencell Bioscience Holdings Ltd | 27.66% | +7.45% |
| UTHR | United Therapeutics Corp | 26.56% | +3.17% |
| LFCR | Lifecore Biomedical Inc | 16.09% | -37.49% |
| PAHC | Phibro Animal Health Corp - Class A | 15.27% | -40.67% |
| ZTS | Zoetis Inc - Class A | 10.56% | -58.98% |
| NBIX | Neurocrine Biosciences Inc | 9.25% | -64.06% |
| PBH | Prestige Consumer Healthcare Inc | 8.18% | -68.22% |
| BCRX | Biocryst Pharmaceuticals Inc | 6.24% | -75.76% |
| BHC | Bausch Health Companies Inc | 2.51% | -90.24% |
| RDY | Dr. Reddy`s Laboratories Ltd | 2.45% | -90.49% |
| YCBD | cbdMD Inc | 1.50% | -94.17% |